Galera Therapeutics (GRTX) Institutional Ownership $0.03 +0.00 (+12.73%) (As of 12/20/2024 03:47 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Galera Therapeutics (NASDAQ:GRTX)CurrentInstitutional OwnershipPercentage50.77%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$130.62KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$36.39K Get GRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Galera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GRTX Institutional Buying and Selling by Quarter Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Galera Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/3/2024 GSA Capital Partners LLP3,632,627$509K0.0%-6.7%6.679% 1/31/2024 abrdn plc898,374$131K0.0%N/A1.652% 8/11/2023 Sectoral Asset Management Inc.2,005,054$6.26M1.0%-4.5%4.673% 8/4/2023 Parallel Advisors LLC7,867$25K0.0%N/A0.018% 8/2/2023Baystate Wealth Management LLC47,695$149K0.0%N/A0.111% 7/27/2023 Pinnacle Associates Ltd.47,695$149K0.0%N/A0.111% Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/24/2023 Vontobel Holding Ltd.20,000$62K0.0%N/A0.047% 7/21/2023 Global Assets Advisory LLC24,500$73K0.1%N/A0.057% 7/11/2023 Good Life Advisors LLC11,250$35K0.0%N/A0.026% 5/12/2023 Sectoral Asset Management Inc.2,098,565$5.37M1.0%+25.9%4.891% 5/12/2023 Mirabella Financial Services LLP57,000$6.66M1.0%N/A0.133% 5/1/2023 Virtu Financial LLC20,195$52K0.0%N/A0.047% 4/14/2023Raymond James Financial Services Advisors Inc.23,475$60K0.0%N/A0.055% 2/10/2023 Sectoral Asset Management Inc.1,666,666$2.48M0.5%N/A5.848% 8/12/2022 Ensign Peak Advisors Inc151,777$197K0.0%+281.6%0.566% 2/11/2022 Ensign Peak Advisors Inc39,775$153K0.0%N/A0.150% 2/10/2022 Acadian Asset Management LLC96,027$439K0.0%N/A0.363% 2/8/2022Raymond James Financial Services Advisors Inc.22,311$102K0.0%-26.3%0.084% 1/28/2022Taylor Wealth Management Partners11,635$53K0.0%-79.9%0.044% 1/25/2022 Belvedere Trading LLC96,486$255K0.0%N/A0.365% 11/17/2021 Altium Capital Management LP300,605$2.44M0.5%+36.7%1.137% 11/15/2021 Marshall Wace LLP83,050$673K0.0%-28.7%0.315% 11/12/2021 AIGH Capital Management LLC2,036,495$16.50M3.5%+0.7%7.724% 10/26/2021Taylor Wealth Management Partners58,012$470K0.2%-11.0%0.220% 9/22/2021 Nan Fung Group Holdings Ltd613,223$6.03M1.9%N/A2.326% 8/25/2021 Marshall Wace LLP116,508$1.15M0.0%+115.3%0.442% 8/17/2021 Worth Venture Partners LLC469,174$4.61M1.7%+119.0%1.779% 8/17/2021 Millennium Management LLC118,548$1.17M0.0%N/A0.450% 8/17/2021 Bridgeway Capital Management LLC110,000$1.08M0.0%+22.2%0.417% 8/16/2021 State Street Corp15,964$157K0.0%-87.5%0.061% 8/16/2021Tibra Equities Europe Ltd36,900$363K0.1%N/A0.140% 8/16/2021 Marshall Wace LLP116,508$1.15M0.0%+115.3%0.442% 8/13/2021 Renaissance Technologies LLC24,170$238K0.0%-34.8%0.092% 8/13/2021 Northern Trust Corp14,795$145K0.0%-84.4%0.056% 8/13/2021 Altium Capital Management LP219,900$2.16M0.5%N/A0.834% 8/13/2021 Jump Financial LLC18,000$177K0.0%N/A0.071% 8/13/2021 Geode Capital Management LLC71,256$700K0.0%-38.7%0.282% 8/13/2021 Vanguard Group Inc.481,524$4.73M0.0%-4.9%1.907% 8/12/2021 AIGH Capital Management LLC2,022,889$19.89M3.6%+121.7%8.010% 8/12/2021 Trexquant Investment LP11,237$110K0.0%N/A0.044% Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover8/12/2021 JPMorgan Chase & Co.35,973$353K0.0%+52.1%0.142% 8/12/2021Ergoteles LLC40,000$393K0.0%N/A0.158% 8/11/2021BlackRock Inc.185,141$1.82M0.0%-68.7%0.733% 8/11/2021 Deutsche Bank AG275,935$2.71M0.0%+4,367.1%1.093% 8/5/2021 US Bancorp DE10,579$104K0.0%N/A0.042% 6/10/2021 Perceptive Advisors LLC254,664$2.25M0.0%-21.6%1.008% 5/19/2021 Worth Venture Partners LLC214,242$1.89M0.9%N/A0.848% 5/17/2021 Schonfeld Strategic Advisors LLC54,488$481K0.0%N/A0.216% 5/17/2021 Perceptive Advisors LLC254,664$2.25M0.0%-21.6%1.008% 5/17/2021 Caas Capital Management LP273,210$2.41M0.0%+53.4%1.082% 5/17/2021 Sphera Funds Management LTD.323,348$2.85M0.2%-30.9%1.280% 5/17/2021 Novo Holdings A S2,459,021$21.69M0.9%-16.9%9.737% 5/17/2021 Goldman Sachs Group Inc.12,805$113K0.0%-21.9%0.051% 5/14/2021Weiss Multi Strategy Advisers LLC26,573$234K0.0%-13.7%0.105% 5/13/2021 Renaissance Technologies LLC37,081$327K0.0%+78.5%0.147% 5/13/2021 Bank of New York Mellon Corp32,303$285K0.0%-5.7%0.128% 5/12/2021 Northern Trust Corp94,945$838K0.0%-3.9%0.376% 5/12/2021 Geode Capital Management LLC116,266$1.03M0.0%+2.2%0.460% 5/12/2021 Panagora Asset Management Inc.36,144$319K0.0%+7.2%0.143% 5/12/2021 UBS Group AG4,349$38K0.0%+122.3%0.017% 5/7/2021BlackRock Inc.591,727$5.22M0.0%+10.2%2.343% 2/25/2021 Hsbc Holdings PLC13,274$140K0.0%N/A0.053% 2/19/2021 JPMorgan Chase & Co.22,564$231K0.0%+262.1%0.090% 2/16/2021 Squarepoint Ops LLC12,428$127K0.0%N/A0.050% 2/12/2021 Caas Capital Management LP178,141$1.82M0.0%N/A0.714% 2/11/2021 Northern Trust Corp98,763$1.01M0.0%-5.0%0.396% 2/11/2021Frazier Management LLC241,000$2.47M0.2%N/A0.966% 2/10/2021 Renaissance Technologies LLC20,770$212K0.0%+58.9%0.083% 2/10/2021 Panagora Asset Management Inc.33,731$345K0.0%+4,795.6%0.135% 2/9/2021 Wells Fargo & Company MN34,611$354K0.0%+407.9%0.139% 2/9/2021 Bank of New York Mellon Corp34,273$351K0.0%+42.0%0.137% 2/8/2021 New York State Common Retirement Fund8,800$90K0.0%+1,000.0%0.035% 2/5/2021BlackRock Inc.536,965$5.49M0.0%+27.1%2.152% 2/4/2021 State of Wisconsin Investment Board12,300$126K0.0%N/A0.049% 2/2/2021Taylor Wealth Management Partners64,753$662K0.3%+4.2%0.260% 11/13/2020 Morgan Stanley2,777$25K0.0%-52.1%0.011% 11/10/2020 State Street Corp82,772$748K0.0%-3.1%0.333% 11/6/2020BlackRock Inc.422,640$3.82M0.0%+6.4%1.699% (Data available from 1/1/2016 forward) GRTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GRTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of Galera Therapeutics. The most heavily invested institutionals were Mirabella Financial Services LLP ($6.66M), Sectoral Asset Management Inc. ($6.26M), GSA Capital Partners LLP ($509K), Baystate Wealth Management LLC ($149K), Pinnacle Associates Ltd. ($149K), abrdn plc ($131K), and Global Assets Advisory LLC ($73K).Learn more on GRTX's institutional investors. What percentage of Galera Therapeutics stock is owned by institutional investors? 50.77% of Galera Therapeutics stock is owned by institutional investors. Learn more on GRTX's institutional investor holdings. Which institutional investors have been buying Galera Therapeutics stock? Of the 11 institutional investors that purchased Galera Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sectoral Asset Management Inc. ($2.10M), abrdn plc ($898.37K), Mirabella Financial Services LLP ($57K), Pinnacle Associates Ltd. ($47.70K), Baystate Wealth Management LLC ($47.70K), Global Assets Advisory LLC ($24.50K), and Raymond James Financial Services Advisors Inc. ($23.48K). How much institutional buying is happening at Galera Therapeutics? Institutional investors have bought a total of 3,256,616 shares in the last 24 months. This purchase volume represents approximately $4.47M in transactions. Which Galera Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Galera Therapeutics stock in the last 24 months: GSA Capital Partners LLP ($259.93K), and Sectoral Asset Management Inc. ($93.51K). How much institutional selling is happening at Galera Therapeutics? Institutional investors have sold a total of 353,445 shares in the last 24 months. This volume of shares sold represents approximately $328.15K in transactions. Related Companies ONVO Institutional Ownership CNSP Institutional Ownership GTBP Institutional Ownership SYRS Institutional Ownership HOTH Institutional Ownership PPBT Institutional Ownership IMCC Institutional Ownership ELAB Institutional Ownership CANF Institutional Ownership BMRA Institutional Ownership This page (NASDAQ:GRTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.